EA1183
FDG PET to Assess Therapeutic Response in Patients with Bone-dominant Metastatic Breast Cancer, FEATURE
Trial overview
| Disease | Breast cancer treatment and diagnosis |
| Topic | EA1183 |
| Description | Primary Objective Evaluate the performance of FDG-PET/CT response criteria (modified PERCIST complete, partial and stable metabolic disease versus progressive metabolic disease) as a binary predictor of PFS in patients with BD MBC treated with systemic therapy |
| Physicians | Dr. Mohammad JahanzebMD, FACP, FASCO Medical Oncologist Works at 2 centers.Dr. Edgardo SantosMD Medical Oncologist Aventura (Medical oncology) |
| Location | Warning: count(): Parameter must be an array or an object that implements Countable in /var/www/html/wp-content/themes/genesiscare/src/components/hcp_clinical_trial_heading/hcp_clinical_trial_heading.php on line 299 Warning: Invalid argument supplied for foreach() in /var/www/html/wp-content/themes/genesiscare/src/components/hcp_clinical_trial_heading/hcp_clinical_trial_heading.php on line 301 |